D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 13.93% -8.48% -0.15% -35.45% 5.28%
Total Depreciation and Amortization -6.54% 4.90% 0.00% -7.27% -3.51%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -18.61% -7.07% -3.85% 12.36% -35.13%
Change in Net Operating Assets -469.25% 12.55% -150.22% 428.76% -19.37%
Cash from Operations -21.33% -9.36% -38.21% -20.12% -9.40%
Capital Expenditure 77.59% -346.15% 45.83% -4.35% -9.52%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -421.72% 133.38% -397.50% -24.98% 173.34%
Cash from Investing -423.67% 133.18% -398.31% -25.03% 174.02%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 51,292.98% -99.80% -- -- --
Repurchase of Common Stock -173.91% 90.80% -54.32% -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 22.08% --
Cash from Financing 64,213.19% -99.84% 2,380.23% 16.75% -33,722.22%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 112.93% -209.11% 264.27% -3,527.40% 97.05%